Everything You Need to Know About Nephron anatomy and function for Step 1

The nephron is one of those Step 1 “small structure, huge consequences” topics: if you can picture where a solute is in the nephron and what transporters are present there, you can predict labs, acid–base status, blood pressure changes, and which diuretic will fix (or cause) the problem. This post walks through nephron anatomy and function in a way that helps you localize pathology and answer USMLE-style questions fast.

---

Nephron at a glance (map it before you memorize it)

A nephron is the kidney’s functional unit: glomerulus + tubules that filter plasma, then selectively reabsorb/secrete solutes and water to maintain homeostasis.

Core nephron segments (in order):

1. Glomerulus + Bowman space
2. Proximal convoluted tubule (PCT)
3. Loop of Henle
   • Thin descending
   • Thin ascending
   • Thick ascending (TAL)
4. Distal convoluted tubule (DCT)
5. Collecting tubule/collecting duct (CD) (cortical → medullary)

Two nephron types (know the distinction):

• Cortical nephrons (most): short loops; less involved in maximal urine concentration.
• Juxtamedullary nephrons: long loops deep into medulla; key for countercurrent gradient and concentrated urine.

---

High-yield renal blood flow anatomy (it’s not just trivia)

Renal microcirculation path:

• Renal artery → afferent arteriole → glomerular capillaries → efferent arteriole → peritubular capillaries (cortical) or vasa recta (juxtamedullary) → renal vein

Why Step questions love “efferent vs afferent”

• Efferent arteriole constriction:
  • ↑ glomerular hydrostatic pressure → ↑ GFR (initially)
  • ↓ renal plasma flow (RPF) → ↑ filtration fraction
  • Can worsen renal ischemia if severe (clinically: NSAIDs vs ACEi/ARB interplay)
• Afferent arteriole constriction:
  • ↓ glomerular pressure → ↓ GFR
  • Classic causes: NSAIDs (↓ PGE₂), hypercalcemia, sympathetic tone

---

Filtration: what crosses the glomerulus, and why?

Filtration barrier layers (high yield)

1. Fenestrated endothelium (blocks cells)
2. Glomerular basement membrane (GBM) (negatively charged; blocks large/neg proteins)
3. Podocyte foot processes with slit diaphragms (nephrin)

Starling forces at the glomerulus

GFR is driven mainly by glomerular capillary hydrostatic pressure and opposed by Bowman space hydrostatic pressure and plasma oncotic pressure.

A common USMLE framing: “What happens to GFR/RPF/FF when X changes arteriolar tone?”

---

Segment-by-segment deep dive (what each part does, what drugs hit it)

1) Proximal Convoluted Tubule (PCT): “bulk reabsorption + bicarbonate”

Reabsorbs (most of it):

• Na⁺, water (iso-osmotic reabsorption)
• Glucose, amino acids (nearly 100% normally)
• HCO₃⁻ (major site)
• Phosphate (regulated by PTH)
• Also reabsorbs some uric acid (but also secretes it—net handling is complex)

Key transporters/processes:

• Na⁺/K⁺ ATPase (basolateral driver everywhere)
• Na⁺/H⁺ exchanger (NHE3) → H⁺ secretion
• Carbonic anhydrase (CA) → enables HCO₃⁻ reabsorption
• SGLT2 (early PCT) and SGLT1 (late PCT): glucose reabsorption

Secreted in PCT:

• H⁺, NH₃/NH₄⁺, organic acids/bases (many drugs)

Clinical/Step associations

• Carbonic anhydrase inhibitors (acetazolamide):
  • ↓ HCO₃⁻ reabsorption → proximal (type 2) RTA-like picture
  • Metabolic acidosis, hypokalemia; alkaline urine
  • Uses: altitude sickness, glaucoma, idiopathic intracranial hypertension
• SGLT2 inhibitors (e.g., empagliflozin):
  • Glycosuria + osmotic diuresis
  • Risks: genital infections, euglycemic DKA (Step 2)

High-yield pathology: Fanconi syndrome (PCT dysfunction)

• What is it? Global PCT reabsorption defect
• Findings: glucosuria (with normal serum glucose), aminoaciduria, phosphaturia → rickets/osteomalacia, bicarbonaturia → metabolic acidosis
• Causes: cystinosis, Wilson disease, outdated tetracyclines, ifosfamide, heavy metals

First Aid cross-ref: Renal Physiology (tubular transport), Diuretics; Renal Tubular Acidosis; Fanconi syndrome.

---

2) Loop of Henle: “make the gradient”

Thin descending limb

• Permeable to water, not to solute → concentrates tubular fluid
• Water leaves into hypertonic medulla

Thin ascending limb

• Impermeable to water
• Passive NaCl reabsorption (less tested than TAL)

Thick ascending limb (TAL): “diluting segment + NKCC”

• Impermeable to water
• Reabsorbs:
  • Na⁺/K⁺/2Cl⁻ via NKCC2
  • Ca²⁺ and Mg²⁺ paracellularly (driven by lumen-positive potential from K⁺ backleak via ROMK)

Clinical/Step associations

• Loop diuretics (furosemide, bumetanide, torsemide, ethacrynic acid):
  • Inhibit NKCC2
  • ↑ urinary Ca²⁺ (used for hypercalcemia)
  • Side effects: Ototoxicity, hypokalemia, metabolic alkalosis, dehydration, sulfa allergy (except ethacrynic acid)
• Bartter syndrome (TAL defect; “like chronic loop diuretic use”)
  • Defect in NKCC2/ROMK/Cl⁻ channels
  • Hypokalemic metabolic alkalosis, normal/low BP
  • ↑ renin/aldosterone; often hypercalciuria

First Aid cross-ref: Diuretics; Bartter vs Gitelman.

---

3) Distal Convoluted Tubule (DCT): “thiazides + calcium reabsorption”

• NaCl reabsorption via NCC (Na⁺/Cl⁻ cotransporter)
• Ca²⁺ reabsorption increases here (via TRPV5; stimulated by PTH)
• Still relatively impermeable to water (early DCT = another diluting segment)

Clinical/Step associations

• Thiazide diuretics (HCTZ, chlorthalidone, indapamide):

  • Inhibit NCC
  • Increase Ca²⁺ reabsorption (helpful in calcium stones due to hypercalciuria)
  • Side effects: hyponatremia, hypokalemic metabolic alkalosis, hyperuricemia, hyperglycemia, hyperlipidemia

• Gitelman syndrome (DCT defect; “like thiazide use”)

  • NCC defect
  • Hypokalemic metabolic alkalosis
  • Hypocalciuria (contrast Bartter)
  • Often hypomagnesemia

First Aid cross-ref: Thiazides; Gitelman.

---

4) Collecting tubule & collecting duct: “fine-tuning + hormones”

This is where the kidney makes final decisions based on hormones.

Principal cells: Na⁺ and water balance; K⁺ secretion

• ENaC reabsorbs Na⁺
• K⁺ secretion (driven by lumen-negative potential)
• Aldosterone:
  • ↑ ENaC and Na⁺/K⁺ ATPase → ↑ Na⁺ reabsorption, ↑ K⁺ secretion, ↑ H⁺ secretion (via α-intercalated cells indirectly)

Intercalated cells: acid–base

• α-intercalated cells: secrete H⁺, reabsorb HCO₃⁻ and K⁺
• β-intercalated cells: secrete HCO₃⁻ (less tested, but conceptually for alkalosis)

ADH and water handling

• ADH (V2 receptor) inserts aquaporin-2 channels in principal cells → ↑ water reabsorption
• In inner medullary collecting duct, ADH also ↑ urea reabsorption (helps maintain medullary hypertonicity)

Clinical/Step associations

• Lithium can cause nephrogenic diabetes insipidus (principal cell resistance to ADH)
• Central DI: low ADH
• Nephrogenic DI: ADH present, kidney doesn’t respond
  • Treatment often includes thiazides and NSAIDs (decrease polyuria by increasing proximal reabsorption and decreasing prostaglandins)

Potassium-sparing diuretics

• Spironolactone/eplerenone: aldosterone receptor antagonists
• Amiloride/triamterene: ENaC blockers
  • Notable: amiloride helps lithium-induced nephrogenic DI
• Side effects: hyperkalemia, metabolic acidosis (type 4 RTA tendency); spironolactone → gynecomastia

First Aid cross-ref: ADH physiology; Diabetes insipidus; Potassium-sparing diuretics; Type 4 RTA.

---

Countercurrent multiplication & exchange (how you concentrate urine)

Countercurrent multiplication (Loop of Henle)

• TAL pumps salt out (NKCC2) but water can’t follow → medullary interstitium becomes hypertonic.
• Descending limb loses water → tubular fluid becomes hypertonic.
• Repeated along loop length → corticomedullary gradient forms.

Countercurrent exchange (Vasa recta)

• Vasa recta preserves gradient via “passive exchange”:
  • Descending vasa recta gains solute/loses water
  • Ascending vasa recta loses solute/gains water
    Net: gradient maintained while still supplying blood flow.

Urea recycling (often overlooked, frequently tested)

• ADH increases urea permeability in inner medullary CD → urea enters medulla → contributes significantly to medullary hypertonicity.

High-yield consequence: Anything that disrupts TAL function (loop diuretics, Bartter) impairs urine-concentrating ability → more dilute urine.

---

Acid–base handling: how the nephron builds “new” bicarbonate

Reclaiming filtered bicarbonate (mostly PCT)

• Filtered HCO₃⁻ is “reabsorbed” indirectly:
  • H⁺ secretion + luminal HCO₃⁻ → H₂CO₃ → CO₂ + H₂O (via CA)
  • CO₂ diffuses into cell → reforms HCO₃⁻ → transported to blood

Generating new bicarbonate (PCT and collecting duct)

• Ammoniagenesis (PCT): glutamine → NH₃ (buffers H⁺ as NH₄⁺) + generates new HCO₃⁻
• α-intercalated cells secrete H⁺ (H⁺-ATPase; H⁺/K⁺ ATPase) and reclaim HCO₃⁻

Clinically relevant pattern recognition (RTA tie-in)

First Aid cross-ref: Renal tubular acidosis; Acid–base physiology.

---

Pathophysiology “localization”: match the defect to the nephron segment

Nephrotic vs nephritic (glomerulus)

When the question emphasizes protein vs blood/casts, think glomerular pathology.

• Nephrotic syndrome: heavy proteinuria (>3.5 g/day), hypoalbuminemia, edema, hyperlipidemia
• Nephritic syndrome: hematuria + RBC casts, HTN, azotemia

Why anatomy matters: glomerular barrier damage can be charge-selective (albumin loss) or structure-selective (RBCs).

Tubulointerstitial injury (PCT/TAL/DCT/CD)

Often gives:

• Mild proteinuria (not massive)
• WBCs, WBC casts (esp. pyelonephritis, AIN)
• Impaired concentrating ability → polyuria/nocturia

Medullary gradient disruption

• TAL inhibition (loop diuretics, Bartter)
• Vasa recta damage (e.g., sickle cell disease trait can cause papillary necrosis and concentrating defects)

---

Clinical presentation patterns you should recognize on sight

1) “Patient on loops has hypokalemic metabolic alkalosis”

• Mechanisms:
  • ↑ Na⁺ delivery to collecting duct → ↑ K⁺ and H⁺ secretion
  • Volume contraction → ↑ aldosterone (“contraction alkalosis”)

2) “Recurrent calcium stones: which diuretic helps?”

• Thiazides: increase Ca²⁺ reabsorption in DCT → ↓ urinary calcium

3) “Polyuria + high serum osmolality”

Differentiate:

• Central DI: responds to desmopressin
• Nephrogenic DI: no response; consider lithium, hypercalcemia, hypokalemia

4) “Normal anion gap metabolic acidosis”

Think RTA:

• Distal: urine pH stays high
• Proximal: other PCT losses (glucose, phosphate, amino acids)
• Type 4: hyperkalemia

---

Diagnosis: what tests map to nephron function?

Urinalysis (UA) & microscopy

• RBC casts: glomerular bleeding (nephritic)
• WBC casts: pyelonephritis or interstitial nephritis
• Muddy brown casts: ATN
• Oval fat bodies: nephrotic syndrome

Fractional excretion (Step 2-ish but shows up)

• FENa helps differentiate prerenal vs intrinsic renal in oliguria:
  • Prerenal: low FENa (kidney avidly reabsorbs Na⁺)
  • ATN: higher FENa (tubules can’t reabsorb)

Urine pH clues

• Persistently alkaline urine with metabolic acidosis → distal RTA (type 1)
• Acidic urine with hyperkalemic metabolic acidosis → type 4 RTA is a strong contender

---

Treatment framework: target the segment/hormone

If the problem is too much Na⁺/water (HTN, edema)

• Loops: strongest; good for pulmonary edema, HF, CKD with low GFR
• Thiazides: great for HTN, mild edema; also prevent Ca stones
• K-sparing: add-on to prevent hypokalemia; useful in hyperaldosteronism

If the problem is acid–base

• Type 1 RTA: alkali therapy (bicarbonate/citrate) + address cause
• Type 2 RTA: bicarbonate often needed (higher doses), treat Fanconi cause
• Type 4 RTA: treat hypoaldosteronism/resistance; consider fludrocortisone in select cases; manage K⁺

If the problem is concentrating defect (DI)

• Central DI: desmopressin
• Nephrogenic DI: stop offending drug (lithium), amiloride for lithium DI, thiazide, NSAIDs, low-salt diet

---

Rapid-fire high-yield associations (USMLE favorites)

Segment → Transporter → Drug/Disorder

Liddle syndrome (super testable)

• Gain-of-function ENaC in collecting duct
• HTN + hypokalemic metabolic alkalosis
• Low renin, low aldosterone
• Treat: amiloride/triamterene (not spironolactone)

NSAIDs vs ACEi/ARB (renal hemodynamics)

• NSAIDs constrict afferent (↓ PGE₂) → ↓ GFR
• ACEi/ARB dilate efferent → ↓ GFR
  Together can precipitate AKI in volume depletion/renal artery stenosis.

First Aid cross-ref: Renal blood flow; Autoregulation; Pharmacology of diuretics; Liddle syndrome.

---

How to study nephron function efficiently (what actually pays off on Step)

If you only do three things:

1. Memorize the segment order and water permeability (descending = water, TAL/DCT = dilute).
2. Anchor each segment to one key transporter (PCT: CA/SGLT; TAL: NKCC; DCT: NCC; CD: ENaC/AQP2).
3. Drill the classic diuretic side effects and Bartter vs Gitelman vs Liddle patterns.

---

First Aid cross-references (quick navigation)

You’ll find this topic spread across:

• Renal Physiology: nephron transport, countercurrent mechanism, urine concentration/dilution
• Pharmacology: diuretics (loops, thiazides, CA inhibitors, K-sparing)
• Pathology: renal tubular acidosis, Fanconi syndrome, glomerular syndromes
• Endocrine: ADH physiology; aldosterone effects (also ties to acid–base and potassium)

(Edition/page numbers vary—use the Renal chapter’s physiology tables + diuretic summary charts as your “home base.”)